@article{ref1,
title="Oxcarbazepine-Induced Hyponatremia: A Case Report and Comprehensive Literature Review",
journal="Curēus",
year="2021",
author="Ejikeme, Chidinma and Elkattawy, Sherif and Kayode-Ajala, Fisayo and Abuaita, Suha and Khazai, Maria",
volume="13",
number="5",
pages="e15085-e15085",
abstract="Oxcarbazepine is a well-known and effective anti-convulsant used for patients with underlying seizure disorder. It is a structural analog of carbamazepine; however, it follows a different metabolic pathway in which it is converted to a different active metabolite. Side effects associated with this medication are vast; however, in this report, we will hone in on the renal adverse effects, e.g., syndrome of inappropriate anti-diuretic hormone secretion (SiADH). SiADH is a condition in which the body is making too much anti-diuretic hormone, which, in turn, results in &quot;too much&quot; water absorption, causing hyponatremia with neurologic sequelae. Our patient is a 31-year-old gentleman with a history of depression, anxiety, bipolar disorder, and previous suicide attempts who presented to the emergency department following oxcarbazepine overdose and was subsequently found to be hyponatremic secondary to having SiADH.<p /><p>Language: en</p>",
language="en",
issn="2168-8184",
doi="10.7759/cureus.15085",
url="http://dx.doi.org/10.7759/cureus.15085"
}